id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT03034213
|
19:26:chronic_disease,30:51:chronic_disease,114:123:treatment
|
Serious or active medical or psychiatric condition which, in the opinion of the Investigator, may interfere with treatment, assessment, or compliance with the protocol
| 3
|
[
"Serious",
"or",
"active",
"medical",
"or",
"psychiatric",
"condition",
"which",
",",
"in",
"the",
"opinion",
"of",
"the",
"Investigator",
",",
"may",
"interfere",
"with",
"treatment",
",",
"assessment",
",",
"or",
"compliance",
"with",
"the",
"protocol"
] |
[
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01789333
|
22:40:treatment
|
A history of delayed epithelial healing
| 3
|
[
"A",
"history",
"of",
"delayed",
"epithelial",
"healing"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT02335671
|
19:41:treatment
|
Participants with prior mantle radiation
| 3
|
[
"Participants",
"with",
"prior",
"mantle",
"radiation"
] |
[
0,
0,
1,
1,
1
] |
NCT02379819
|
20:32:chronic_disease
|
Normal to moderate hearing loss in the low frequencies with severe to profound mid to high frequency hearing loss in the ear to be implanted
| 3
|
[
"Normal",
"to",
"moderate",
"hearing",
"loss",
"in",
"the",
"low",
"frequencies",
"with",
"severe",
"to",
"profound",
"mid",
"to",
"high",
"frequency",
"hearing",
"loss",
"in",
"the",
"ear",
"to",
"be",
"implanted"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02588391
|
1:17:chronic_disease,
|
Born prematurely at <33 weeks gestation
| 3
|
[
"Born",
"prematurely",
"at",
"<",
"33",
"weeks",
"gestation"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT02064036
|
1:38:treatment,21:38:treatment,43:58:cancer,
|
Prior pharmacologic androgen ablation for prostate cancer is allowed only if the onset of androgen ablation is ≤ 60 days prior to the date of registration
| 3
|
[
"Prior",
"pharmacologic",
"androgen",
"ablation",
"for",
"prostate",
"cancer",
"is",
"allowed",
"only",
"if",
"the",
"onset",
"of",
"androgen",
"ablation",
"is",
"≤",
"60",
"days",
"prior",
"to",
"the",
"date",
"of",
"registration"
] |
[
1,
1,
1,
1,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03089905
|
34:45:allergy_name
|
Previous adverse reaction to any anaesthetic
| 3
|
[
"Previous",
"adverse",
"reaction",
"to",
"any",
"anaesthetic"
] |
[
0,
0,
0,
0,
0,
4
] |
NCT03121586
|
1:17:treatment
|
Abilify Maintena
| 3
|
[
"Abilify",
"Maintena"
] |
[
1,
1
] |
NCT02419560
|
24:37:chronic_disease
|
Significant history of heart disease
| 3
|
[
"Significant",
"history",
"of",
"heart",
"disease"
] |
[
0,
0,
0,
2,
2
] |
NCT02186418
|
13:40:treatment
|
Patients on chronic transfusion therapy for severe disease symptoms other than those listed above, and which interfere with normal life activities
| 3
|
[
"Patients",
"on",
"chronic",
"transfusion",
"therapy",
"for",
"severe",
"disease",
"symptoms",
"other",
"than",
"those",
"listed",
"above",
",",
"and",
"which",
"interfere",
"with",
"normal",
"life",
"activities"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03038269
|
8:18:chronic_disease
|
Severe spasticity
| 3
|
[
"Severe",
"spasticity"
] |
[
0,
2
] |
NCT01626079
|
75:84:treatment
|
The primary regurgitant jet is non-commissural, and in the opinion of the MitraClip implanting investigator can be successfully be treated by the MitraClip
| 3
|
[
"The",
"primary",
"regurgitant",
"jet",
"is",
"non-commissural",
",",
"and",
"in",
"the",
"opinion",
"of",
"the",
"MitraClip",
"implanting",
"investigator",
"can",
"be",
"successfully",
"be",
"treated",
"by",
"the",
"MitraClip"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02749968
|
,6:19:chronic_disease
|
> 20 rib fractures
| 3
|
[
">",
"20",
"rib",
"fractures"
] |
[
0,
0,
2,
2
] |
NCT01174121
|
,,39:49:treatment
|
ANC > 1000/mm3 without the support of filgrastim
| 3
|
[
"ANC",
">",
"1000/mm3",
"without",
"the",
"support",
"of",
"filgrastim"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02299414
|
1:20:chronic_disease
|
Sickle cell disease
| 3
|
[
"Sickle",
"cell",
"disease"
] |
[
2,
2,
2
] |
NCT02290951
|
32:35:chronic_disease
|
History of or current relevant CNS pathology
| 3
|
[
"History",
"of",
"or",
"current",
"relevant",
"CNS",
"pathology"
] |
[
0,
0,
0,
0,
0,
2,
0
] |
NCT01445821
|
1:24:chronic_disease
|
Ventricular tachycardia (sustained or non-sustained, multifocal or unifocal) on EKG or 24 hour Holter
| 3
|
[
"Ventricular",
"tachycardia",
"(",
"sustained",
"or",
"non-sustained",
",",
"multifocal",
"or",
"unifocal",
")",
"on",
"EKG",
"or",
"24",
"hour",
"Holter"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03061903
|
1:9:chronic_disease
|
Diabetes
| 3
|
[
"Diabetes"
] |
[
2
] |
NCT03181126
|
13:25:treatment,26:44:treatment,50:67:treatment,
|
An excluded antiplatelet/anticoagulant drug or a herbal supplement that affects platelet function within 7 days, or 5 half-lives, whichever is longer
| 3
|
[
"An",
"excluded",
"antiplatelet/anticoagulant",
"drug",
"or",
"a",
"herbal",
"supplement",
"that",
"affects",
"platelet",
"function",
"within",
"7",
"days",
",",
"or",
"5",
"half-lives",
",",
"whichever",
"is",
"longer"
] |
[
0,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00630565
|
1:52:treatment,
|
Allogeneic transplant with an HLA-identical sibling will be recommended for patients <55 years
| 3
|
[
"Allogeneic",
"transplant",
"with",
"an",
"HLA-identical",
"sibling",
"will",
"be",
"recommended",
"for",
"patients",
"<",
"55",
"years"
] |
[
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01898793
|
21:45:cancer,
|
Patients with known CNS involvement with AML are eligible provided that they have been treated and CSF is clear for at least 2 weeks prior to enrollment into the study
| 3
|
[
"Patients",
"with",
"known",
"CNS",
"involvement",
"with",
"AML",
"are",
"eligible",
"provided",
"that",
"they",
"have",
"been",
"treated",
"and",
"CSF",
"is",
"clear",
"for",
"at",
"least",
"2",
"weeks",
"prior",
"to",
"enrollment",
"into",
"the",
"study"
] |
[
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01597518
|
1:10:treatment
|
Phenytoin
| 3
|
[
"Phenytoin"
] |
[
1
] |
NCT01087294
|
23:27:chronic_disease,60:70:chronic_disease,75:87:chronic_disease,101:135:treatment,
|
Either no evidence of GVHD or minimal clinical evidence of acute GVHD and chronic GVHD while off of systemic immunosuppressive therapy for at least 28 days
| 3
|
[
"Either",
"no",
"evidence",
"of",
"GVHD",
"or",
"minimal",
"clinical",
"evidence",
"of",
"acute",
"GVHD",
"and",
"chronic",
"GVHD",
"while",
"off",
"of",
"systemic",
"immunosuppressive",
"therapy",
"for",
"at",
"least",
"28",
"days"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02518594
|
5:10:chronic_disease,11:29:chronic_disease,82:91:treatment,151:187:chronic_disease
|
Any fetal/maternal condition which would require invasive in-utero assessment or treatment, for example significant red cell antigen sensitization or neonatal alloimmune thrombocytopenia
| 3
|
[
"Any",
"fetal/maternal",
"condition",
"which",
"would",
"require",
"invasive",
"in-utero",
"assessment",
"or",
"treatment",
",",
"for",
"example",
"significant",
"red",
"cell",
"antigen",
"sensitization",
"or",
"neonatal",
"alloimmune",
"thrombocytopenia"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02194738
|
5:13:treatment
|
pre-surgical patients
| 3
|
[
"pre-surgical",
"patients"
] |
[
1,
0
] |
NCT02426476
|
1:26:chronic_disease
|
uncontrolled hypertension
| 3
|
[
"uncontrolled",
"hypertension"
] |
[
2,
2
] |
NCT02910700
|
21:40:cancer,64:69:treatment,72:80:treatment,83:89:treatment,106:121:treatment
|
Prior therapies for metastatic melanoma are allowed, including chemo-, cytokine-, immuno, biological and vaccine-therapy as long as they did not include BRAFi, MEKi
| 3
|
[
"Prior",
"therapies",
"for",
"metastatic",
"melanoma",
"are",
"allowed",
",",
"including",
"chemo-",
",",
"cytokine-",
",",
"immuno",
",",
"biological",
"and",
"vaccine-therapy",
"as",
"long",
"as",
"they",
"did",
"not",
"include",
"BRAFi",
",",
"MEKi"
] |
[
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02776891
|
25:28:treatment,35:44:treatment,46:60:treatment,69:83:chronic_disease
|
No contraindications to MRI (e.g. pacemaker, aneurysm clips, severe claustrophobia)
| 3
|
[
"No",
"contraindications",
"to",
"MRI",
"(",
"e.g",
".",
"pacemaker",
",",
"aneurysm",
"clips",
",",
"severe",
"claustrophobia",
")"
] |
[
0,
0,
0,
1,
0,
0,
0,
1,
0,
1,
1,
0,
0,
2,
0
] |
NCT03079297
|
21:44:treatment,
|
Stable doses of all concomitant medications for over 6 weeks
| 3
|
[
"Stable",
"doses",
"of",
"all",
"concomitant",
"medications",
"for",
"over",
"6",
"weeks"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT03125226
|
15:40:cancer
|
Treatment for metastatic bladder cancer
| 3
|
[
"Treatment",
"for",
"metastatic",
"bladder",
"cancer"
] |
[
0,
0,
3,
3,
3
] |
NCT02847988
|
13:34:chronic_disease
|
Acute-onset neuromuscular disease
| 3
|
[
"Acute-onset",
"neuromuscular",
"disease"
] |
[
0,
2,
2
] |
NCT02101944
|
1:20:chronic_disease,,
|
Renal insufficiency: serum creatinine > 2 mg/dL
| 3
|
[
"Renal",
"insufficiency",
":",
"serum",
"creatinine",
">",
"2",
"mg/dL"
] |
[
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01349101
|
57:68:chronic_disease
|
Patients who require supplemental oxygen other than for sleep apnea
| 3
|
[
"Patients",
"who",
"require",
"supplemental",
"oxygen",
"other",
"than",
"for",
"sleep",
"apnea"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03112824
|
16:28:treatment
|
Taking chronic anti-anxiety
| 3
|
[
"Taking",
"chronic",
"anti-anxiety"
] |
[
0,
0,
1
] |
NCT03125902
|
1:27:chronic_disease
|
uncontrolled hypercalcemia
| 3
|
[
"uncontrolled",
"hypercalcemia"
] |
[
2,
2
] |
NCT03104517
|
17:44:chronic_disease,
|
Patient has had stress urinary incontinence symptoms less than 6 months prior to signing the informed consent
| 3
|
[
"Patient",
"has",
"had",
"stress",
"urinary",
"incontinence",
"symptoms",
"less",
"than",
"6",
"months",
"prior",
"to",
"signing",
"the",
"informed",
"consent"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02172651
|
,,145:155:treatment,169:182:treatment,199:224:treatment
|
Pregnant and nursing women are excluded from this study because there is an unknown but potential risk of adverse events related to higher-dose vitamin D3 and colon or liver surgery (and associated perioperative medications and anesthesia) on the human fetus
| 3
|
[
"Pregnant",
"and",
"nursing",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"there",
"is",
"an",
"unknown",
"but",
"potential",
"risk",
"of",
"adverse",
"events",
"related",
"to",
"higher-dose",
"vitamin",
"D3",
"and",
"colon",
"or",
"liver",
"surgery",
"(",
"and",
"associated",
"perioperative",
"medications",
"and",
"anesthesia",
")",
"on",
"the",
"human",
"fetus"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01884740
|
1:24:treatment,32:47:treatment,51:59:treatment,,137:146:treatment
|
Radiographic procedures (e.g., Gd-enhanced MRI or CT scans) documenting existing lesions must have been performed within three weeks of treatment on this research study
| 3
|
[
"Radiographic",
"procedures",
"(",
"e.g.",
",",
"Gd-enhanced",
"MRI",
"or",
"CT",
"scans",
")",
"documenting",
"existing",
"lesions",
"must",
"have",
"been",
"performed",
"within",
"three",
"weeks",
"of",
"treatment",
"on",
"this",
"research",
"study"
] |
[
1,
1,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT01943851
|
35:64:treatment,96:108:treatment,110:120:treatment,122:143:treatment,148:163:treatment,,213:222:treatment
|
the subject has been off systemic immunosuppressive medications (including but not limited to: cyclosporine, tacrolimus, mycophenolate mofetil, or corticosteroids) for at least 1 month prior to the first dose of GSK525762
| 3
|
[
"the",
"subject",
"has",
"been",
"off",
"systemic",
"immunosuppressive",
"medications",
"(",
"including",
"but",
"not",
"limited",
"to",
":",
"cyclosporine",
",",
"tacrolimus",
",",
"mycophenolate",
"mofetil",
",",
"or",
"corticosteroids",
")",
"for",
"at",
"least",
"1",
"month",
"prior",
"to",
"the",
"first",
"dose",
"of",
"GSK525762"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02333162
|
1:22:chronic_disease
|
Cytomegalovirus (CMV) status
| 3
|
[
"Cytomegalovirus",
"(",
"CMV",
")",
"status"
] |
[
2,
2,
0,
0,
0
] |
NCT02056288
|
18:35:allergy_name
|
Known allergy to local anesthetics
| 3
|
[
"Known",
"allergy",
"to",
"local",
"anesthetics"
] |
[
0,
0,
0,
4,
4
] |
NCT02389517
|
5:32:cancer
|
Any measurable residual disease at the time of screening for the study
| 3
|
[
"Any",
"measurable",
"residual",
"disease",
"at",
"the",
"time",
"of",
"screening",
"for",
"the",
"study"
] |
[
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02520011
|
16:54:cancer
|
Diagnosed with acute promyelocytic leukemia (APL, M3)
| 3
|
[
"Diagnosed",
"with",
"acute",
"promyelocytic",
"leukemia",
"(",
"APL",
",",
"M3",
")"
] |
[
0,
0,
3,
3,
3,
3,
3,
0,
0,
0
] |
NCT02525692
|
,23:35:treatment
|
Must be 12 weeks from radiotherapy
| 3
|
[
"Must",
"be",
"12",
"weeks",
"from",
"radiotherapy"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT02865135
|
1:19:chronic_disease,29:57:chronic_disease,61:81:chronic_disease,119:144:treatment
|
Autoimmune disease, such as systemic lupus erythematosis or rheumatoid arthritis, that is active and requires current immunosuppressive therapy
| 3
|
[
"Autoimmune",
"disease",
",",
"such",
"as",
"systemic",
"lupus",
"erythematosis",
"or",
"rheumatoid",
"arthritis",
",",
"that",
"is",
"active",
"and",
"requires",
"current",
"immunosuppressive",
"therapy"
] |
[
2,
2,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01614990
|
71:74:treatment
|
Conditions that would preclude from successfully scanning subjects in MRI
| 3
|
[
"Conditions",
"that",
"would",
"preclude",
"from",
"successfully",
"scanning",
"subjects",
"in",
"MRI"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03174834
|
1:17:chronic_disease
|
Critical illness
| 3
|
[
"Critical",
"illness"
] |
[
2,
2
] |
NCT02385110
|
,,,181:191:treatment
|
Recommendation is for male and partner to use at least 2 effective contraceptive methods, as described above, prior to study entry and for at least 3 months after the last dose of study drug
| 3
|
[
"Recommendation",
"is",
"for",
"male",
"and",
"partner",
"to",
"use",
"at",
"least",
"2",
"effective",
"contraceptive",
"methods",
",",
"as",
"described",
"above",
",",
"prior",
"to",
"study",
"entry",
"and",
"for",
"at",
"least",
"3",
"months",
"after",
"the",
"last",
"dose",
"of",
"study",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02433626
|
1:7:chronic_disease,9:31:chronic_disease,33:38:chronic_disease,40:46:chronic_disease,57:80:chronic_disease,91:107:treatment
|
Active, uncontrolled bacterial, viral, fungal, or other opportunistic infection requiring systemic therapy
| 3
|
[
"Active",
",",
"uncontrolled",
"bacterial",
",",
"viral",
",",
"fungal",
",",
"or",
"other",
"opportunistic",
"infection",
"requiring",
"systemic",
"therapy"
] |
[
2,
0,
2,
2,
0,
2,
0,
2,
0,
0,
0,
2,
2,
0,
1,
1
] |
NCT02468778
|
25:54:chronic_disease,61:84:chronic_disease,130:149:chronic_disease
|
The presence of complex coronary artery disease (CAD) makes hemodynamic instability resulting from repeat episodes of reversible myocardial ischemia during PCI likely
| 3
|
[
"The",
"presence",
"of",
"complex",
"coronary",
"artery",
"disease",
"(",
"CAD",
")",
"makes",
"hemodynamic",
"instability",
"resulting",
"from",
"repeat",
"episodes",
"of",
"reversible",
"myocardial",
"ischemia",
"during",
"PCI",
"likely"
] |
[
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0
] |
NCT02278250
|
,,,,,123:133:treatment
|
Female participants who are already pregnant or lactating, or plan to become pregnant within 6 months of the last dose of study drug
| 3
|
[
"Female",
"participants",
"who",
"are",
"already",
"pregnant",
"or",
"lactating",
",",
"or",
"plan",
"to",
"become",
"pregnant",
"within",
"6",
"months",
"of",
"the",
"last",
"dose",
"of",
"study",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02495389
|
25:36:treatment,
|
Must not have taken any antibiotics, for any reason, in the 4 weeks prior to enrollment
| 3
|
[
"Must",
"not",
"have",
"taken",
"any",
"antibiotics",
",",
"for",
"any",
"reason",
",",
"in",
"the",
"4",
"weeks",
"prior",
"to",
"enrollment"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03036280
|
1:19:chronic_disease
|
hearing impairment
| 3
|
[
"hearing",
"impairment"
] |
[
2,
2
] |
NCT02611063
|
13:44:cancer
|
Evidence of relapsed hematologic malignancy based on routine restaging studies
| 3
|
[
"Evidence",
"of",
"relapsed",
"hematologic",
"malignancy",
"based",
"on",
"routine",
"restaging",
"studies"
] |
[
0,
0,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT01951885
|
31:85:treatment
|
Patients must be undergoing a myeloablative allogeneic hematopoietic cell transplant with one of the following conditioning regimens
| 3
|
[
"Patients",
"must",
"be",
"undergoing",
"a",
"myeloablative",
"allogeneic",
"hematopoietic",
"cell",
"transplant",
"with",
"one",
"of",
"the",
"following",
"conditioning",
"regimens"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03087903
|
30:33:allergy_name,35:53:allergy_name,83:101:allergy_name
|
Known allergy/intolerance to soy, phosphatidycholine or any other constituents of grape seed extract
| 3
|
[
"Known",
"allergy/intolerance",
"to",
"soy",
",",
"phosphatidycholine",
"or",
"any",
"other",
"constituents",
"of",
"grape",
"seed",
"extract"
] |
[
0,
0,
0,
4,
0,
4,
0,
0,
0,
0,
0,
4,
4,
4
] |
NCT02826668
|
31:51:allergy_name
|
absolute contraindications of neuraxial anesthesia including patient refusal
| 3
|
[
"absolute",
"contraindications",
"of",
"neuraxial",
"anesthesia",
"including",
"patient",
"refusal"
] |
[
0,
0,
0,
4,
4,
0,
0,
0
] |
NCT02321501
|
,,79:93:treatment,,
|
Male sterilization (at least 6 months prior to screening)with the appropriate post-vasectomy documentation of the absence of sperm in the ejaculate. For female subjects on the study the vasectomized male partner should be the sole partner for that subject
| 3
|
[
"Male",
"sterilization",
"(",
"at",
"least",
"6",
"months",
"prior",
"to",
"screening",
")",
"with",
"the",
"appropriate",
"post-vasectomy",
"documentation",
"of",
"the",
"absence",
"of",
"sperm",
"in",
"the",
"ejaculate",
".",
"For",
"female",
"subjects",
"on",
"the",
"study",
"the",
"vasectomized",
"male",
"partner",
"should",
"be",
"the",
"sole",
"partner",
"for",
"that",
"subject"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02514083
|
1:16:cancer,28:35:cancer,40:60:cancer
|
Transformed CLL, including Hodgkin and non-Hodgkin lymphoma
| 3
|
[
"Transformed",
"CLL",
",",
"including",
"Hodgkin",
"and",
"non-Hodgkin",
"lymphoma"
] |
[
3,
3,
0,
0,
3,
0,
3,
3
] |
NCT02479698
|
22:32:chronic_disease,,
|
Patients with active acute GVHD grades II-IV
| 3
|
[
"Patients",
"with",
"active",
"acute",
"GVHD",
"grades",
"II-IV"
] |
[
0,
0,
0,
2,
2,
0,
0
] |
NCT02240498
|
31:51:treatment
|
Necrotic tissue that requires surgical debridement
| 3
|
[
"Necrotic",
"tissue",
"that",
"requires",
"surgical",
"debridement"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT02332369
|
1:8:chronic_disease
|
uveitis
| 3
|
[
"uveitis"
] |
[
2
] |
NCT02046395
|
12:33:treatment
|
History or renal transplantation
| 3
|
[
"History",
"or",
"renal",
"transplantation"
] |
[
0,
0,
1,
1
] |
NCT02911116
|
45:56:allergy_name
|
Participant has a known hypersensitivity to ustekinumab or any of its components
| 3
|
[
"Participant",
"has",
"a",
"known",
"hypersensitivity",
"to",
"ustekinumab",
"or",
"any",
"of",
"its",
"components"
] |
[
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0
] |
NCT01568177
|
1:24:chronic_disease
|
Acute coronary syndrome (defined by the ACC/AHA criteria, Braunwald 2000)
| 3
|
[
"Acute",
"coronary",
"syndrome",
"(",
"defined",
"by",
"the",
"ACC/AHA",
"criteria",
",",
"Braunwald",
"2000",
")"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02911467
|
1:25:chronic_disease,,
|
Congestive heart failure or New York Heart Association (NYHA) status ≥ 2
| 3
|
[
"Congestive",
"heart",
"failure",
"or",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"status",
"≥",
"2"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02270450
|
68:86:treatment
|
Serum albumin must be planned to be collected after admission, but prior to treatment
| 3
|
[
"Serum",
"albumin",
"must",
"be",
"planned",
"to",
"be",
"collected",
"after",
"admission",
",",
"but",
"prior",
"to",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02004028
|
39:59:cancer,49:59:cancer,,125:153:cancer,189:204:cancer,,238:253:cancer,
|
Subjects being actively treated for a secondary malignancy or any malignancy within the last 3 years, with the exception of non-melanomatous skin cancer or localized, definitively treated cervical cancer. Men under observation for local prostate cancer are also eligible if they have had stable disease for at least 1 year
| 3
|
[
"Subjects",
"being",
"actively",
"treated",
"for",
"a",
"secondary",
"malignancy",
"or",
"any",
"malignancy",
"within",
"the",
"last",
"3",
"years",
",",
"with",
"the",
"exception",
"of",
"non-melanomatous",
"skin",
"cancer",
"or",
"localized",
",",
"definitively",
"treated",
"cervical",
"cancer",
".",
"Men",
"under",
"observation",
"for",
"local",
"prostate",
"cancer",
"are",
"also",
"eligible",
"if",
"they",
"have",
"had",
"stable",
"disease",
"for",
"at",
"least",
"1",
"year"
] |
[
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02236013
|
,,92:102:treatment
|
must agree not to try to become pregnant during the study and for 180 days after the final study drug administration
| 3
|
[
"must",
"agree",
"not",
"to",
"try",
"to",
"become",
"pregnant",
"during",
"the",
"study",
"and",
"for",
"180",
"days",
"after",
"the",
"final",
"study",
"drug",
"administration"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02541903
|
1:14:chronic_disease
|
malabsorption
| 3
|
[
"malabsorption"
] |
[
2
] |
NCT02013154
|
13:47:chronic_disease,63:74:chronic_disease,103:114:chronic_disease,
|
Known to be human immunodeficiency virus (HIV) positive, have hepatitis B surface antigen (HBSAg), or hepatitis C antibodies (HCAb) unless HCV RNA is undetected/negative
| 3
|
[
"Known",
"to",
"be",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"positive",
",",
"have",
"hepatitis",
"B",
"surface",
"antigen",
"(",
"HBSAg",
")",
",",
"or",
"hepatitis",
"C",
"antibodies",
"(",
"HCAb",
")",
"unless",
"HCV",
"RNA",
"is",
"undetected/negative"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02593110
|
13:19:chronic_disease
|
increase in angina, angina at rest
| 3
|
[
"increase",
"in",
"angina",
",",
"angina",
"at",
"rest"
] |
[
0,
0,
2,
0,
0,
0,
0
] |
NCT01505569
|
17:27:cancer,31:52:cancer,,117:145:treatment
|
Other High Risk Metastatic or Relapsed Solid Tumors - to be approved by 2 or more pediatric hematology/oncology and bone marrow transplant (BMT) physicians
| 3
|
[
"Other",
"High",
"Risk",
"Metastatic",
"or",
"Relapsed",
"Solid",
"Tumors",
"-",
"to",
"be",
"approved",
"by",
"2",
"or",
"more",
"pediatric",
"hematology/oncology",
"and",
"bone",
"marrow",
"transplant",
"(",
"BMT",
")",
"physicians"
] |
[
0,
0,
0,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT02864147
|
30:40:treatment
|
Patients with unsatisfactory colposcopy
| 3
|
[
"Patients",
"with",
"unsatisfactory",
"colposcopy"
] |
[
0,
0,
0,
1
] |
NCT02230605
|
,,25:46:chronic_disease,57:73:chronic_disease,75:88:chronic_disease,90:98:chronic_disease
|
History of Axis I or II psychiatric disorders including bipolar disorder, schizophrenia, dementia, alcohol or drug abuse
| 3
|
[
"History",
"of",
"Axis",
"I",
"or",
"II",
"psychiatric",
"disorders",
"including",
"bipolar",
"disorder",
",",
"schizophrenia",
",",
"dementia",
",",
"alcohol",
"or",
"drug",
"abuse"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
0,
2,
0,
0,
0,
0,
0
] |
NCT03017937
|
12:33:chronic_disease,44:63:chronic_disease,68:86:chronic_disease
|
History of neurological deficits, previous cerebral infarction, or severe head trauma as indicated through pre-season screening
| 3
|
[
"History",
"of",
"neurological",
"deficits",
",",
"previous",
"cerebral",
"infarction",
",",
"or",
"severe",
"head",
"trauma",
"as",
"indicated",
"through",
"pre-season",
"screening"
] |
[
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02234934
|
7:25:chronic_disease
|
Major congenital anomaly
| 3
|
[
"Major",
"congenital",
"anomaly"
] |
[
0,
2,
2
] |
NCT03152383
|
16:22:chronic_disease
|
Presence of an autism diagnosis as determined by The Autism Diagnostic Observation Schedule (ADOS)
| 3
|
[
"Presence",
"of",
"an",
"autism",
"diagnosis",
"as",
"determined",
"by",
"The",
"Autism",
"Diagnostic",
"Observation",
"Schedule",
"(",
"ADOS",
")"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01804465
|
30:46:treatment,70:96:treatment,98:119:treatment,,206:229:treatment,
|
Patients receiving any other hormonal therapy, including any dose of megestrol acetate (Megace), Proscar (finasteride), any herbal product known to decrease PSA levels (e.g. Saw Palmetto, PC-SPES), or any systemic corticosteroid, must discontinue the agent for at least four weeks prior to study treatment. Progressive disease as defined above must be documented after discontinuation of any hormonal therapy
| 3
|
[
"Patients",
"receiving",
"any",
"other",
"hormonal",
"therapy",
",",
"including",
"any",
"dose",
"of",
"megestrol",
"acetate",
"(",
"Megace",
")",
",",
"Proscar",
"(",
"finasteride",
")",
",",
"any",
"herbal",
"product",
"known",
"to",
"decrease",
"PSA",
"levels",
"(",
"e.g",
".",
"Saw",
"Palmetto",
",",
"PC-SPES",
")",
",",
"or",
"any",
"systemic",
"corticosteroid",
",",
"must",
"discontinue",
"the",
"agent",
"for",
"at",
"least",
"four",
"weeks",
"prior",
"to",
"study",
"treatment",
".",
"Progressive",
"disease",
"as",
"defined",
"above",
"must",
"be",
"documented",
"after",
"discontinuation",
"of",
"any",
"hormonal",
"therapy"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02847689
|
12:45:chronic_disease
|
History of Central Nervous System infections
| 3
|
[
"History",
"of",
"Central",
"Nervous",
"System",
"infections"
] |
[
0,
0,
2,
2,
2,
2
] |
NCT01420887
|
45:65:chronic_disease,74:94:chronic_disease,96:125:chronic_disease,129:141:chronic_disease
|
Progressive or recurrent contracture due to inflammatory disease such as rheumatoid arthritis, juvenile idiopathic arthritis or chondrolysis
| 3
|
[
"Progressive",
"or",
"recurrent",
"contracture",
"due",
"to",
"inflammatory",
"disease",
"such",
"as",
"rheumatoid",
"arthritis",
",",
"juvenile",
"idiopathic",
"arthritis",
"or",
"chondrolysis"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
2,
2,
2,
0,
2
] |
NCT01576575
|
35:59:chronic_disease
|
Good general health with no known major medical conditions
| 3
|
[
"Good",
"general",
"health",
"with",
"no",
"known",
"major",
"medical",
"conditions"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02176161
|
18:30:cancer
|
history of other malignancies
| 3
|
[
"history",
"of",
"other",
"malignancies"
] |
[
0,
0,
0,
3
] |
NCT02353819
|
8:18:treatment
|
repeat ultrasound measurement after hormone downsizing
| 3
|
[
"repeat",
"ultrasound",
"measurement",
"after",
"hormone",
"downsizing"
] |
[
0,
1,
0,
0,
0,
0
] |
NCT03158974
|
100:114:allergy_name,116:126:allergy_name,148:184:allergy_name,190:200:allergy_name,202:209:allergy_name,211:218:allergy_name
|
Have a known sensitivity to any of the constituents of the test product including sensitivities to sandalwood oil, fragrances or any member of the Compositae family of vascular plants (eg, sunflowers, daisies, dahlias, etc.)
| 3
|
[
"Have",
"a",
"known",
"sensitivity",
"to",
"any",
"of",
"the",
"constituents",
"of",
"the",
"test",
"product",
"including",
"sensitivities",
"to",
"sandalwood",
"oil",
",",
"fragrances",
"or",
"any",
"member",
"of",
"the",
"Compositae",
"family",
"of",
"vascular",
"plants",
"(",
"eg",
",",
"sunflowers",
",",
"daisies",
",",
"dahlias",
",",
"etc",
".",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
4,
0,
4,
0,
0,
0,
0,
0,
4,
4,
4,
4,
4,
0,
0,
0,
4,
0,
4,
0,
4,
0,
0,
0,
0
] |
NCT02687464
|
25:37:chronic_disease
|
suspicion of perforated appendicitis
| 3
|
[
"suspicion",
"of",
"perforated",
"appendicitis"
] |
[
0,
0,
0,
2
] |
NCT02834403
|
11:31:treatment,
|
Use of an investigational drug within 14 days preceding the first dose of study medication
| 3
|
[
"Use",
"of",
"an",
"investigational",
"drug",
"within",
"14",
"days",
"preceding",
"the",
"first",
"dose",
"of",
"study",
"medication"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02187848
|
,78:104:chronic_disease,106:120:chronic_disease,122:150:chronic_disease,152:174:chronic_disease,180:207:chronic_disease
|
Any of the following within 6 months prior to study enrolment: infectious or inflammatory bowel disease, diverticulitis, gastrointestinal perforation, intestinal obstruction, and gastrointestinal hemorrhage
| 3
|
[
"Any",
"of",
"the",
"following",
"within",
"6",
"months",
"prior",
"to",
"study",
"enrolment",
":",
"infectious",
"or",
"inflammatory",
"bowel",
"disease",
",",
"diverticulitis",
",",
"gastrointestinal",
"perforation",
",",
"intestinal",
"obstruction",
",",
"and",
"gastrointestinal",
"hemorrhage"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0
] |
NCT02646787
|
11:22:treatment
|
Receiving prophylaxis for alcohol or drug withdrawal
| 3
|
[
"Receiving",
"prophylaxis",
"for",
"alcohol",
"or",
"drug",
"withdrawal"
] |
[
0,
1,
0,
0,
0,
0,
0
] |
NCT02416102
|
1:20:treatment,
|
Oral corticosteroid use within 6 weeks of the screening visit
| 3
|
[
"Oral",
"corticosteroid",
"use",
"within",
"6",
"weeks",
"of",
"the",
"screening",
"visit"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03038269
|
1:8:chronic_disease,,
|
Seizure beyond age 2
| 3
|
[
"Seizure",
"beyond",
"age",
"2"
] |
[
2,
0,
0,
0
] |
NCT02105766
|
15:34:chronic_disease,36:41:chronic_disease,43:45:chronic_disease,50:61:chronic_disease,138:161:chronic_disease,242:253:treatment
|
Patients with sickle cell disease (Hb SS, SC, or S beta-thal) at high risk for disease-related morbidity or mortality, defined by having severe end-organ damage (A, B, C, D, or E) or potentially modifiable complication(s) not ameliorated by hydroxyurea (F)
| 3
|
[
"Patients",
"with",
"sickle",
"cell",
"disease",
"(",
"Hb",
"SS",
",",
"SC",
",",
"or",
"S",
"beta-thal",
")",
"at",
"high",
"risk",
"for",
"disease-related",
"morbidity",
"or",
"mortality",
",",
"defined",
"by",
"having",
"severe",
"end-organ",
"damage",
"(",
"A",
",",
"B",
",",
"C",
",",
"D",
",",
"or",
"E",
")",
"or",
"potentially",
"modifiable",
"complication",
"(",
"s",
")",
"not",
"ameliorated",
"by",
"hydroxyurea",
"(",
"F",
")"
] |
[
0,
0,
2,
2,
2,
0,
2,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02520778
|
25:50:chronic_disease,92:113:chronic_disease,124:141:treatment
|
Past medical history of interstitial lung disease, drug-induced interstitial lung disease, radiation pneumonitis requiring steroid treatment, or any evidence of clinically active interstitial lung disease
| 3
|
[
"Past",
"medical",
"history",
"of",
"interstitial",
"lung",
"disease",
",",
"drug-induced",
"interstitial",
"lung",
"disease",
",",
"radiation",
"pneumonitis",
"requiring",
"steroid",
"treatment",
",",
"or",
"any",
"evidence",
"of",
"clinically",
"active",
"interstitial",
"lung",
"disease"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01815359
|
28:46:cancer
|
Subjects with a history of endometrial cancer are eligible only if they presented with a stage lower than 1A and if the histology was a subtype other than poorly differentiated
| 3
|
[
"Subjects",
"with",
"a",
"history",
"of",
"endometrial",
"cancer",
"are",
"eligible",
"only",
"if",
"they",
"presented",
"with",
"a",
"stage",
"lower",
"than",
"1A",
"and",
"if",
"the",
"histology",
"was",
"a",
"subtype",
"other",
"than",
"poorly",
"differentiated"
] |
[
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03072238
|
1:10:chronic_disease
|
cirrhosis
| 3
|
[
"cirrhosis"
] |
[
2
] |
NCT01750567
|
47:75:cancer
|
Patients should have a confirmed diagnosis of chronic lymphocytic leukemia
| 3
|
[
"Patients",
"should",
"have",
"a",
"confirmed",
"diagnosis",
"of",
"chronic",
"lymphocytic",
"leukemia"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT02389023
|
26:46:treatment,51:78:chronic_disease,,138:170:treatment,
|
Patients who received an investigational drug for peripheral arterial disease within 4 weeks of screening or who participated in another non-observational clinical trial in the prior 30 days
| 3
|
[
"Patients",
"who",
"received",
"an",
"investigational",
"drug",
"for",
"peripheral",
"arterial",
"disease",
"within",
"4",
"weeks",
"of",
"screening",
"or",
"who",
"participated",
"in",
"another",
"non-observational",
"clinical",
"trial",
"in",
"the",
"prior",
"30",
"days"
] |
[
0,
0,
0,
0,
1,
1,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT01685411
|
34:49:chronic_disease,57:69:chronic_disease,71:78:chronic_disease
|
hepatic: no clinical evidence of hepatic failure (e.g., coagulopathy, ascites)
| 3
|
[
"hepatic",
":",
"no",
"clinical",
"evidence",
"of",
"hepatic",
"failure",
"(",
"e.g.",
",",
"coagulopathy",
",",
"ascites",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0
] |
NCT02584647
|
1:25:treatment,41:57:chronic_disease,,130:143:treatment
|
Major surgical procedure or significant traumatic injury within 14 days of initiating study drug or anticipation of the need for major surgery during the study
| 3
|
[
"Major",
"surgical",
"procedure",
"or",
"significant",
"traumatic",
"injury",
"within",
"14",
"days",
"of",
"initiating",
"study",
"drug",
"or",
"anticipation",
"of",
"the",
"need",
"for",
"major",
"surgery",
"during",
"the",
"study"
] |
[
1,
1,
1,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT01714596
|
15:36:chronic_disease
|
patients with chronic osteomyelitis identified by radiographic erosion or sequestrum
| 3
|
[
"patients",
"with",
"chronic",
"osteomyelitis",
"identified",
"by",
"radiographic",
"erosion",
"or",
"sequestrum"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.